Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1994 |
| gptkbp:ATCCode |
gptkb:C10AA04
|
| gptkbp:contraindication |
pregnancy
breastfeeding active liver disease |
| gptkbp:drugClass |
statin
|
| gptkbp:eliminatedIn |
bile
|
| gptkbp:form |
capsule
extended-release tablet |
| gptkbp:genericName |
gptkb:fluvastatin
|
| gptkbp:halfLife |
0.5-1.2 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lescol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
HMG-CoA reductase inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
muscle pain liver enzyme abnormalities |
| gptkbp:usedFor |
gptkb:familial_hypercholesterolemia
prevention of cardiovascular disease |
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|